Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation
Journal of Enzyme Inhibition and Medicinal Chemistry · 2023
DOI: 10.1080/14756366.2023.2220558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2023. Verfasst von Yonghua Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nantong First People's Hospital, Nantong, China. Hauptthemen laut MEDLINE: Drug Discovery, HSP90 Heat-Shock Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Research Hospital Association for Precision Medication, Fengcheng Talent Plan Youth Science and Technology Talent Recruitment Project of Taizhou.
Abstract (Originalsprache)
Heat shock protein 90 (Hsp90) is considered an attractive therapeutic target for cancer treatment due to its high expression in many cancers. In this study, four potent Hsp90 inhibitors (HPs 1-4) were identified using structure-based virtual screening. Among them, HP-4 exhibited the most potent inhibitory effects (IC50 = 17.64 ± 1.45 nM) against the Hsp90 protein, which was about 7.7 times stronger than that of MPC-3100 (a positive inhibitor targeting Hsp90). In vitro cytotoxicity assay suggested that HP-4 could effectively inhibit the proliferation of a series of tumour cells, including HCT-116, HeLa, A549, A2780, DU145, HepG2 and A498. Furthermore, in vivo assay displayed that HP-4 had significant anti-tumour effects on HCT-116 cell-derived xenograft models. These data demonstrate that HP-4 could be a potential lead compound for the further investigation of anti-tumour drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Nantong First People's Hospital, Nantong, China.
- Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.
- Department of Oncology, Urology and Pharmacy, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
Förderung
- Jiangsu Research Hospital Association for Precision Medication
- Fengcheng Talent Plan Youth Science and Technology Talent Recruitment Project of Taizhou
Zitieren
APA
Xu, Y., Zou, Y., Zhou, S., Niu, M. M., Zhang, Y., Li, J., Xu, Z., & Yang, L. (2023). Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2023.2220558
Vancouver
Xu Y, Zou Y, Zhou S, Niu MM, Zhang Y, Li J, et al. Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. 2023. doi:10.1080/14756366.2023.2220558
BibTeX
@article{Xu2023,
author = {Xu, Yonghua and Zou, Yunting and Zhou, Shasha and Niu, Miao-Miao and Zhang, Yan and Li, Jindong and Xu, Zhen and Yang, Li},
title = {Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation},
journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
year = {2023},
doi = {10.1080/14756366.2023.2220558}
}
EUVIMED